The effect of β‐glucan administration on macrophage respiratory burst activity and Atlantic salmon, Salmo salar L., challenged with amoebic gill disease – evidence of inherent resistance

• Published in: Journal of Fish Diseases
• Main Authors: Bridle, A R, Carter, C G, Morrison, R N, Nowak, B F
• Format: Article in Journal/Newspaper
• Language: English
• Published: Wiley 2005
• Subjects: Atlantic salmon; Salmo salar
• Online Access: http://dx.doi.org/10.1111/j.1365-2761.2005.00636.x; https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2761.2005.00636.x; https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2761.2005.00636.x

Abstract Previous studies have demonstrated that β ‐glucans stimulate Atlantic salmon, Salmo salar L., head kidney macrophages both in vitro and in vivo and increase protection against various pathogens. Based on our previous work that showed potent immunostimulatory CpG motif‐containing oligodeoxynucleotides increased resistance to amoebic gill disease (AGD), the present study investigated the immunostimulatory effects of three commercial β ‐glucan‐containing feeds and their ability to increase resistance to AGD. All three commercial β ‐glucans were able to stimulate the respiratory burst activity of Atlantic salmon head kidney macrophages in vitro , albeit at different times and concentrations. However, dietary incorporation of the β ‐glucans was unable to stimulate the in vivo respiratory burst activity of head kidney macrophages, or serum lysozyme production, and did not increase resistance against AGD. However, this trial showed for the first time that a small subpopulation of Atlantic salmon subjected to a severe AGD infection was able to resist becoming heavily infected and furthermore survive the challenge.